
    
      This study is being conducted to assess the relative bioavailability of naproxen and
      esomeprazole from a single dose of PN 400 (delayed-release naproxen 500mg / immediate-release
      esomeprazole 20mg), enteric-coated naproxen 500mg co-administered with enteric-coated
      esomeprazole 20mg, enteric-coated naproxen 500mg administered alone, and enteric-coated
      esomeprazole 20mg administered alone.
    
  